Project/Area Number |
20591950
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Obstetrics and gynecology
|
Research Institution | Yamaguchi University |
Principal Investigator |
MURAKAMI Akihiro Yamaguchi University, 医学部附属病院, 講師 (70379965)
|
Co-Investigator(Kenkyū-buntansha) |
NAWATA Shugo 山口大学, 医学部付属病院, 准教授 (60294625)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2010: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
|
Keywords | SCC抗原 / carbonyl reductase (CR) / 予後判定 / carbonyl reductase / がんの浸潤・転移 / 分子標的治療 / 癌の浸潤・転移 / 癌の予後診断 |
Research Abstract |
The SCC antigen binds to the protein, which was identified to be carbonyl reductase (CR). The immunostaining analyses revealed that CR is located in the cytoplasm of keratinocytes and the normal squamous epithelial cells of the uterine cervix as well as SCCA1 and SCCA2. Sense and antisense CR cDNAs were transfected into a human uterine SCC cell lines to investigate the role of CR in cancer cell invasion and metastasis. In an in vitro experiment, suppression of CR showed morphology changes to like fibroblast, increased cancer cell invasion, secretion of MMP. On the other hand, over-expression of CR decreased MMP secretion. Paraffin sections from uterine cervical SCC tissues, FIGO stage Ib1-IIb were immunostained with anti-CR antibodies. Overall survival (OS) and progression-free survival (PFS) were analyzed by the Kaplan-Meier method. Immunohistochemical analyses showed that reduced CR expression patterns in primary cancer lesions were closely associated with a high incidence of pelvic lymph node metastasis, poor OS, and poor PFS.
|